Daniel S. Lorrain - Chief Scientific Officer at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
CTNM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Daniel S. Lorrain since 9/11/2023

Holdings reported by Daniel S. Lorrain for Contineum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 176K Apr 4, 2024 Direct
Stock Option (right to buy) 100K May 24, 2024 Direct Class A Common Stock
Stock Option (right to buy) 3.7K May 24, 2024 By Spouse Class A Common Stock
Class A Common Stock 3.57K Apr 4, 2024 By Spouse

Transactions reported by Daniel S. Lorrain for Contineum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.